Protease Inhibitor–Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
Open Access
- 28 February 2011
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 140 (2), 667-675
- https://doi.org/10.1053/j.gastro.2010.10.056
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C PatientsGastroenterology, 2010
- MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A ProteaseAntimicrobial Agents and Chemotherapy, 2010
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patientsHepatology, 2009
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV InfectionNew England Journal of Medicine, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)Antimicrobial Agents and Chemotherapy, 2008
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive SubjectsThe Journal of Infectious Diseases, 2008
- Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor TelaprevirGastroenterology, 2007
- SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 NonrespondersGastroenterology, 2007
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002